Hyperbaric Oxygen Therapy Versus High Power Laser for Diabetic Neuropathy (HBOT-HPLT-DPN)
Hyperbaric Oxygen Therapy Versus High Power Laser Therapy On Sensorimotor Functions In Patients With Diabetic Peripheral Neuropathy
The purpose of this study is to compare the clinical effects of Hyperbaric Oxygen Therapy (HBOT) versus High-Intensity Laser Therapy (HPLT) on sensorimotor functions and nerve conduction in patients suffering from painful diabetic peripheral neuropathy.
Participants are divided into three equal groups. The first group receives a traditional physiotherapy program focused on ankle and foot exercises. The second group receives hyperbaric oxygen therapy sessions in addition to the traditional program. The third group receives high-power MLS laser therapy alongside the traditional program. Investigators look at whether either advanced intervention shows superiority in improving nerve functionality and reducing neuropathic pain.
調査の概要
状態
詳細な説明
Diabetic peripheral neuropathy (DPN) is a major microvascular complication of diabetes leading to progressive nerve damage and neuropathic pain. This randomized controlled trial evaluates and compares the efficacy of two non-pharmacological interventions: Hyperbaric Oxygen Therapy (HBOT) and High-Intensity Laser Therapy (HPLT).
A total of 66 medically controlled patients with painful diabetic neuropathy are randomly assigned into three equal parallel groups (22 patients per group):
- Control Group (A): Receives a traditional physiotherapy program including foot and ankle ROM exercises, strengthening, and functional walking training for 5 sessions per week for 3 weeks.
- Study Group (B): Receives Hyperbaric Oxygen Therapy (100% oxygen at 2.5 ATA for 60 minutes, totaling 90 minutes per session) for 15 sessions over 3 weeks, combined with the traditional physiotherapy program.
- Study Group (C): Receives High-Power Laser Therapy using a Multiwave Locked System (MLS) laser device (1500 Hz frequency) applied every other day for 9 sessions over 3 weeks, combined with the traditional physiotherapy program.
Assessments are conducted before and after the 3-week treatment period using objective Nerve Conduction Studies (NCS) for the sural and common peroneal nerves, and subjective screening via the Arabic Michigan Neuropathy Screening Instrument (MNSI) score.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Cairo Governorate
-
Cairo、Cairo Governorate、エジプト、11771
- Kobri El Koba Military Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Patients diagnosed with type 2 diabetes mellitus for more than 5 years.
- Presence of painful diabetic peripheral neuropathy lasting for more than 6 months.
- Presence of sensory abnormalities, burning pain, and impaired nerve conduction velocity in the lower extremities.
- Medically controlled glycemic status.
- Sufficient cognitive abilities with a Mini-Mental State Examination (MMSE) score greater than 24.
- Fit for hyperbaric pressure therapy with a cardiac ejection fraction (CEF) equal to or greater than 50% and blood pressure equal to or less than 150/90 mmHg.
Exclusion Criteria:
- Peripheral neuropathy resulting from causes other than diabetes (e.g., vitamin B12 deficiency, alcohol abuse, or trauma).
- Severe vascular insufficiency in the lower limbs.
- Uncontrolled medical conditions such as tumors or thyroid dysfunction.
- Pregnancy.
- Presence of metallic implantations or cardiac pacemakers.
- Severe visual, auditory, or cognitive impairment (MMSE score less than 24).
- Chronic obstructive pulmonary disease (COPD) or other contraindications to hyperbaric oxygen therapy.
- History of other neurological diseases (e.g., stroke or multiple sclerosis).
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Conventional Physiotherapy
Foot and ankle range of motion (ROM) exercises, strengthening exercises, functional exercises, and walking training (5 sessions per week for 3 weeks). |
Foot and ankle range of motion (ROM) exercises, strengthening exercises, functional exercises, and walking training (5 sessions per week for 3 weeks) |
|
実験的：Hyperbaric Oxygen Therapy (HBOT)
Conventional physiotherapy program plus HBOT sessions (100% oxygen at 2.5 ATA for 60 minutes, with 15 minutes gradual compression and 15 minutes decompression, totaling 90 minutes per session). 15 sessions over 3 weeks. |
100% oxygen inhalation at 2.5 ATA pressure for 60 minutes inside a hyperbaric chamber.
他の名前：
|
|
実験的：High-Power Laser Therapy (HPLT)
Conventional physiotherapy program plus HPLT (MLS laser, M6). Applied every other day for 9 sessions over 3 weeks. Includes a remote foot scan followed by contact application on 7 specific lower extremity areas. |
MLS laser (M6 device) at 1500 Hz frequency, applied every other day for 9 sessions over 3 weeks. Includes a remote foot scan followed by contact application on 7 specific lower extremity areas.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Michigan Neuropathy Screening Instrument (MNSI) score
時間枠：Baseline and 3 weeks post-treatment
|
The Michigan Neuropathy Screening Instrument (MNSI) questionnaire was used to assess symptoms of diabetic peripheral neuropathy. Abnormal responses were summed to obtain the total score. The questionnaire score ranges from 0 to 13, with higher scores indicating greater neuropathic symptom burden. |
Baseline and 3 weeks post-treatment
|
|
Change in right sural nerve distal sensory latency
時間枠：Baseline and after 3 weeks of treatment
|
Right sural nerve distal sensory latency was assessed using nerve conduction studies and measured in milliseconds (ms). |
Baseline and after 3 weeks of treatment
|
|
Change in left sural nerve distal sensory latency
時間枠：Baseline and after 3 weeks of treatment
|
Left sural nerve distal sensory latency was assessed using nerve conduction studies and measured in milliseconds (ms). |
Baseline and after 3 weeks of treatment
|
|
Change in right sural nerve sensory amplitude
時間枠：Baseline and after 3 weeks of treatment
|
Right sural nerve sensory amplitude was assessed using nerve conduction studies and measured in microvolts (µV). |
Baseline and after 3 weeks of treatment
|
|
Change in left sural nerve sensory amplitude
時間枠：Baseline and after 3 weeks of treatment
|
Left sural nerve sensory amplitude was assessed using nerve conduction studies and measured in microvolts (µV). |
Baseline and after 3 weeks of treatment
|
|
Change in right sural nerve conduction velocity
時間枠：Baseline and after 3 weeks of treatment
|
Right sural nerve conduction velocity was assessed using nerve conduction studies and measured in meters per second (m/s). |
Baseline and after 3 weeks of treatment
|
|
Change in left sural nerve conduction velocity
時間枠：Baseline and after 3 weeks of treatment
|
Left sural nerve conduction velocity was assessed using nerve conduction studies and measured in meters per second (m/s). |
Baseline and after 3 weeks of treatment
|
|
Change in right peroneal nerve distal motor latency
時間枠：Baseline and after 3 weeks of treatment
|
Right peroneal nerve distal motor latency was assessed using nerve conduction studies and measured in milliseconds (ms). |
Baseline and after 3 weeks of treatment
|
|
Change in left peroneal nerve distal motor latency
時間枠：Baseline and after 3 weeks of treatment
|
Left peroneal nerve distal motor latency was assessed using nerve conduction studies and measured in milliseconds (ms). |
Baseline and after 3 weeks of treatment
|
|
Change in right peroneal nerve motor amplitude
時間枠：Baseline and after 3 weeks of treatment
|
Right peroneal nerve motor amplitude was assessed using nerve conduction studies and measured in millivolts (mV). |
Baseline and after 3 weeks of treatment
|
|
Change in left peroneal nerve motor amplitude
時間枠：Baseline and after 3 weeks of treatment
|
Left peroneal nerve motor amplitude was assessed using nerve conduction studies and measured in millivolts (mV). |
Baseline and after 3 weeks of treatment
|
|
Change in right peroneal nerve motor conduction velocity
時間枠：Baseline and after 3 weeks of treatment
|
Right peroneal nerve motor conduction velocity was assessed using nerve conduction studies and measured in meters per second (m/s). |
Baseline and after 3 weeks of treatment
|
|
Change in left peroneal nerve motor conduction velocit
時間枠：Baseline and after 3 weeks of treatment
|
Left peroneal nerve motor conduction velocity was assessed using nerve conduction studies and measured in meters per second (m/s). |
Baseline and after 3 weeks of treatment
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- P.T.REC/012/005181
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared outside the research team to maintain patient privacy and data confidentiality in accordance with institutional guidelines.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。